LARIMAR THERAPEUTICS, INC. Interest Receivable, Current
LARIMAR THERAPEUTICS, INC. (LRMR) had Interest Receivable, Current of $267.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes
us-gaap:InterestReceivableCurrent · last filed 2026-08-04
- 2026-06-30: Interest Receivable, Current $267.00K.
- 2026-03-31: Interest Receivable, Current $791.00K.
- 2025-12-31: Interest Receivable, Current $747.00K.
- 2025-09-30: Interest Receivable, Current $1.00M.
| Period end | Interest Receivable, Current |
|---|---|
| 2026-06-30 | $267.00K 10-Q · filed 2026-08-04 |
| 2026-03-31 | $791.00K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $747.00K 10-Q · filed 2026-08-04 |
| 2025-09-30 | $1.00M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $983.00K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $1.06M 10-Q · filed 2025-04-30 |
| 2024-12-31 | $1.05M 10-K · filed 2026-03-19 |
| 2024-09-30 | $943.00K 10-Q · filed 2024-10-30 |
| 2024-06-30 | $751.00K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $1.08M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $332.00K 10-K · filed 2025-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |